欧洲血管外科学会2023版《血管疾病抗血栓治疗临床实践指南》解读——下肢动脉硬化性疾病

Interpretation of the European Society for Vascular Surgery(ESVS)2023 Clinical Practice Guidelines for Antithrombotic Therapy in Vascular Diseases-atherosclerotic lower extremity arterial disease

欧洲血管外科学会(ESVS)首次发布了2023版《血管疾病抗血栓治疗临床实践指南》,对下肢动脉硬化性疾病(LEAD)的抗血栓策略进行了详细的介绍和更新,并给出了21条具体的推荐。LEAD患病率和相关的公共卫生费用都在不断增加,抗血栓治疗是LEAD患者的治疗基石。因此,笔者根据指南的循证医学证据,结合临床实际,重点对LEAD的抗血栓策略进行解读,希望能够帮助医务工作者更好地理解和遵循指南。

The European Society for Vascular Surgery(ESVS)has released the 2023 edition of the"Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases"for the first time.The guidelines provide a detailed introduction and updates on the antithrombotic strategies for atherosclerotic lower extremity arterial disease(LEAD),along with 21 specific recommendations.The prevalence of LEAD and its associated public health costs continue to rise,making antithrombotic therapy a cornerstone in treating LEAD patients.Therefore,the authors interpret the antithrombotic strategies for LEAD,focusing on evidence-based medicine from the guidelines and considering clinical practice,hoping to assist healthcare professionals in better understanding and adhering to the guidelines.